Acutus Medical Inc (AFIB) - Total Liabilities
Based on the latest financial reports, Acutus Medical Inc (AFIB) has total liabilities worth $40.24 Million USD as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Acutus Medical Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Acutus Medical Inc - Total Liabilities Trend (2018–2024)
This chart illustrates how Acutus Medical Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Acutus Medical Inc.
Acutus Medical Inc Competitors by Total Liabilities
The table below lists competitors of Acutus Medical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Logistics Development Group PLC
LSE:LDG
|
UK | GBX375.00K |
|
Vast Resources PLC
LSE:VAST
|
UK | GBX32.29 Million |
|
Jubilee Platinum
LSE:JLP
|
UK | GBX102.29 Million |
|
4BASEBIO UK SOCIETAS
LSE:4BB
|
UK | GBX19.44 Million |
|
Spectra Systems Corp
LSE:SPSY
|
UK | GBX21.01 Million |
|
GeoVax Labs Inc
NASDAQ:GOVX
|
USA | $1.82 Million |
|
Braemar Plc
LSE:BMS
|
UK | GBX69.89 Million |
|
Urbanimmersive Inc
V:UI
|
Canada | CA$13.49 Million |
Liability Composition Analysis (2018–2024)
This chart breaks down Acutus Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Acutus Medical Inc (AFIB) balance sheet quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -3.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Acutus Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Acutus Medical Inc (2018–2024)
The table below shows the annual total liabilities of Acutus Medical Inc from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $40.24 Million | -26.62% |
| 2023-12-31 | $54.84 Million | -6.13% |
| 2022-12-31 | $58.42 Million | -8.81% |
| 2021-12-31 | $64.07 Million | -2.86% |
| 2020-12-31 | $65.95 Million | -80.09% |
| 2019-12-31 | $331.27 Million | +109.97% |
| 2018-12-31 | $157.77 Million | -- |
About Acutus Medical Inc
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well a… Read more